The largest database of trusted experimental protocols

Human trustain fcx blocker

Manufactured by BioLegend

The Human TruStain FcX blocker is a reagent used to block Fc receptors in flow cytometry experiments. It is designed to prevent non-specific binding of antibodies to Fc receptors, improving the accuracy of cell surface marker detection.

Automatically generated - may contain errors

2 protocols using human trustain fcx blocker

1

Quantification of HIV-Specific Antibody Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raji‐Env and Raji‐Ctr cells (1 × 105) were washed in PBS containing 2% HI‐FBS, and pre‐incubated with 5 μL of Human TruStain FcX blocker (BioLegend) in 100 μl staining volume for 5 min at RT. Subsequently, the cells were incubated with or without 30 μg/ml of anti‐HIV antibodies for 45 min at 4°C. Cells were prepared for flow cytometry by washing once with PBS containing 2% HI‐FBS followed by incubation with 5 μl of Brilliant Violet 421 anti‐human IgG Fc Antibody (clone M1310G05) (Biolegend) or 0.015 μg of Brilliant Violet 421 Streptavidin (BioLegend) in 100 μl staining volume for 20 min at 4°C. The gating strategy for flow cytometry analysis is shown in Fig EV5.
+ Open protocol
+ Expand
2

Quantifying Complement-Mediated Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raji‐Env and Raji‐Ctr cells (5 × 104) were resuspended in 100 μl RPMI containing 25% NHS from healthy donors and 100 U/ml P/S. Cells were seeded in a 96‐well culture plate and incubated for 1 and 24 h at 37°C with or without 10 μg/ml antibody or BiCE (unless otherwise stated), and with or without a C3 nanobody inhibitor (hC3Nb2) using C3:hC3Nb2 molar ratio of 1:4. HC3Nb2 has previously been described by H. Pedersen and GR Andersen (Pedersen et al, 2020 (link)). After 1 and 24 h, the cells were prepared for flow cytometry. To measure CDC, cells were stained with 1 μl of the live/dead marker Zombie Violet Fixable Viability Stain (Biolegend) in 100 μl staining volume for 30 min at 4°C. Complement‐dependent cytotoxicity was determined using the following formula: 100 × (% of dead cells with antibody − % of dead cells without antibody) / (100 − % of dead cells without antibody). Negative values were set to zero. Second, to measure complement deposition, cells were pre‐incubated with 5 μl of Human TruStain FcX blocker (BioLegend) in 100 μl staining volume for 5 min at RT, followed by incubation with 5 μl of APC anti‐complement C3b/iC3b Antibody (clone 3E7/C3b) (BioLegend) or 5 μl of APC Mouse IgG1, κ Isotype Ctrl Antibody (clone MOPC‐21) (BioLegend) in 100 μl staining volume for 20 min at 4°C. The gating strategy for flow cytometry analysis is shown in Fig EV5.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!